FDA Will Summarily Deny Petitions Submitted Solely To Block ANDA Approvals
This article was originally published in The Pink Sheet Daily
Executive Summary
Draft guidance in implementation of FDAAA provision outlines how FDA will weed out and deny petitions “with a primary purpose of delaying approval of an application.”.